The announcement of a significant private placement of common stock typically indicates investor confidence and can lead to an increase in share price due to perceived future growth and financial stability. For Ventyx Biosciences, this $100 million infusion is likely viewed positively by the market, reflecting expectations of positive future developments for the company.